mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.3 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.4 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.4 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |